No one knows how long they will live, which makes it hard to know how much money you'll need in order to retire. But several approaches can help people nearing retirement make their money last.
A line of immortal cells, supposedly from a breast cancer patient, turned out to be from a type of skin cancer. The mix-up wasn't discovered until experiments around the world had been contaminated.
Billionaire Paul Allen's new institute in Seattle will examine how the cells in your body work — and how and why they malfunction, leading to tumors, Alzheimer's and other diseases.
The Senate's release will focus on case studies of the treatment, at times brutal, of 20 or so high-value detainees in the counterterrorism efforts following 9/11, and whether those methods paid off.
Both American and European authorities are angry about Irish rules that let firms pay as 12.5 percent taxes, or nearly a third the U.S. rate. Some officials think it may qualify as illegal state aid.
The FAA has been struggling to write the rules for unmanned aircraft like the ones Amazon and other companies are developing. But a proposal is finally expected this month.
A new study is focusing on what works best to prepare kids for school. Math may be what really counts, say researchers, one of who describes it as "a lever to improve outcomes for kids longer term."
An NPR probe finds many nursing homes still are prescribing schizophrenia drugs to calm dementia patients — despite FDA warnings — but only 2 percent of excessive-medication cases result in penalties.
The legendary composer and singer showed up at NPR's Culver City studios just before the dead of night to talk about her "helium voice," overcoming polio and painting songs with Bob Dylan.